The earnings call reflected strong sales growth and profitability improvements, with significant gains in key growth segments and an upgraded full-year outlook. While challenges were noted in the China market and research funding pressures, these were outweighed by the company's positive performance and strategic initiatives.

Company Guidance -

Q3 2025

During the Q2 2025 earnings call, QIAGEN provided an optimistic guidance bolstered by strong performance metrics. The company reported a 7% increase in net sales to $534 million, with a 6% growth at constant exchange rates (CER). Core sales, which exclude discontinued products, also grew 6% CER compared to the previous year. Adjusted diluted earnings per share (EPS) stood at $0.60 and $0.62 at CER, surpassing their target due to improved operational profitability. Growth pillars such as QIAstat and QuantiFERON exhibited robust performance, with QIAstat growing 41% at CER and QuantiFERON by 11% CER. For the full year 2025, QIAGEN upgraded its net sales outlook to a 4-5% growth at CER and core sales growth to 5-6% CER. The adjusted EPS outlook was confirmed at approximately $2.35 at CER. Additionally, QIAGEN announced a strategic focus on increasing shareholder value, including plans for a synthetic share repurchase up to $500 million and maintaining a strong balance sheet to support future growth initiatives.

Sales and Profitability Growth

Net sales rose 7% to $534 million with 6% growth at constant exchange rates. Adjusted diluted EPS was $0.60 and $0.62 at CER, ahead of targets, driven by strong improvements in operational profitability.

Strong Growth in Key Segments

QIAstat grew 41% at CER driven by strong instrument placements. QuantiFERON grew 11% CER with solid gains in the Americas and EMEA. QIAcuity delivered double-digit CER growth supported by high demand for consumables.

Upgraded Full-Year Outlook

Upgraded full-year '25 sales outlook to 4% to 5% net sales growth at constant exchange rates, up from the previous target of about 4% growth. Expecting 5% to 6% CER growth in the core portfolio.

Operating Margin Improvement

Adjusted operating income margin rose to 29.9% of sales, up 1.5 percentage points from the same quarter last year, driven by efficiency initiatives.

Strong Cash Flow and Shareholder Returns

Net cash from operating activities was USD 301 million. Over $350 million returned to shareholders in 2025 through share repurchases and dividends.

Qiagen (QGEN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

QGEN Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 04, 2025	2025 (Q3)	0.59 / -	0.586	―	―	―
Aug 05, 2025	2025 (Q2)	0.60 / 0.60	0.566	6.01% (+0.03)
May 07, 2025	2025 (Q1)	0.50 / 0.55	0.473	16.28% (+0.08)
Feb 05, 2025	2024 (Q4)	0.62 / 0.61	0.566	7.77% (+0.04)
Nov 06, 2024	2024 (Q3)	0.56 / 0.59	0.53	10.57% (+0.06)
Jul 31, 2024	2024 (Q2)	0.54 / 0.57	0.541	4.62% (+0.02)
Apr 29, 2024	2024 (Q1)	0.45 / 0.47	0.541	-12.57% (-0.07)
Feb 06, 2024	2023 (Q4)	0.57 / 0.57	0.562	0.71% (<+0.01)
Oct 30, 2023	2023 (Q3)	0.51 / 0.53	0.562	-5.69% (-0.03)
Aug 08, 2023	2023 (Q2)	0.53 / 0.54	0.541	0.00% (0.00)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

QGEN Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 05, 2025	$49.95	$47.49	-4.92%
May 07, 2025	$42.41	$41.94	-1.11%
Feb 05, 2025	$43.57	$42.22	-3.10%
Nov 06, 2024	$43.64	$43.91	+0.62%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Qiagen NV (QGEN) report earnings?

Qiagen NV (QGEN) is schdueled to report earning on Nov 04, 2025, After Close (Confirmed).

What is Qiagen NV (QGEN) earnings time?

Qiagen NV (QGEN) earnings time is at Nov 04, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is QGEN EPS forecast?

QGEN EPS forecast for the fiscal quarter 2025 (Q3) is 0.59.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing